Concord Medical Services Holdings Ltd (CCM)
0.8016
-0.37
(-31.48%)
USD |
NYSE |
Jun 25, 16:00
0.75
-0.05
(-6.44%)
After-Hours: 20:00
Concord Medical Services Holdings Revenue (Annual): 75.97M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 75.97M |
| December 31, 2022 | 70.28M |
| December 31, 2021 | 75.21M |
| December 31, 2020 | 32.32M |
| December 31, 2019 | 28.72M |
| December 31, 2018 | 28.88M |
| December 31, 2017 | 49.06M |
| December 31, 2016 | 68.35M |
| Date | Value |
|---|---|
| December 31, 2015 | 98.11M |
| December 31, 2014 | 98.48M |
| December 31, 2013 | 91.56M |
| December 31, 2012 | 72.12M |
| December 31, 2011 | 69.57M |
| December 31, 2010 | 57.42M |
| December 31, 2009 | 42.87M |
| December 31, 2008 | 24.76M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
28.72M
Minimum
2019
75.97M
Maximum
2023
56.50M
Average
70.28M
Median
2022
Revenue (Annual) Benchmarks
| Dr Reddy's Laboratories Ltd | 3.372B |
| ASLAN Pharmaceuticals Ltd | 12.00M |
| Zai Lab Ltd | 266.72M |
| 111 Inc | 2.113B |
| Sinovac Biotech Ltd | 448.27M |